PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsAchilles Therapeutics
Achilles Therapeutics(ACHL)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
No data
Revenue by Drug
Loading
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Mk3475
pancreatic neoplasms
,
head and neck neoplasms
,
small cell carcinoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
squamous cell neoplasms
,
neoplasm metastasis
,
renal cell carcinoma
,
colorectal neoplasms
,
carcinoma
,
neoplasms
,
transitional cell carcinoma
,
non-small-cell lung carcinoma
,
breast neoplasms
,
lymphoma
,
hodgkin disease
,
squamous cell carcinoma of head and neck
,
melanoma
,
squamous cell carcinoma
,
adenocarcinoma
,
non-hodgkin lymphoma
,
lung neoplasms
,
follicular lymphoma
,
urethral neoplasms
,
ureteral neoplasms
,
pelvic neoplasms
,
urologic neoplasms
,
multiple myeloma
,
brain neoplasms
,
central nervous system diseases
,
triple negative breast neoplasms
,
prostatic neoplasms
,
small cell lung carcinoma
,
esophageal squamous cell carcinoma
,
uveal melanoma
,
t-cell lymphoma
,
immunoblastic lymphadenopathy
,
enteropathy-associated t-cell lymphoma
,
t-cell lymphoma peripheral
,
invasive hydatidiform mole
,
urinary bladder neoplasms
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use